Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 11

1.

JNK Pathway-Associated Phosphatase/DUSP22 Suppresses CD4+ T-Cell Activation and Th1/Th17-Cell Differentiation and Negatively Correlates with Clinical Activity in Inflammatory Bowel Disease.

Zhou R, Chang Y, Liu J, Chen M, Wang H, Huang M, Liu S, Wang X, Zhao Q.

Front Immunol. 2017 Jul 4;8:781. doi: 10.3389/fimmu.2017.00781. eCollection 2017.

2.

Expression of the chemokine receptor gene, CCR8, is associated With DUSP22 rearrangements in anaplastic large cell lymphoma.

Xing X, Flotte TJ, Law ME, Blahnik AJ, Chng WJ, Huang G, Knudson RA, Ketterling RP, Porcher JC, Ansell SM, Sidhu J, Dogan A, Feldman AL.

Appl Immunohistochem Mol Morphol. 2015 Sep;23(8):580-9. doi: 10.1097/PAI.0000000000000118.

3.

Patterns of somatically acquired amplifications and deletions in apparently normal tissues of ovarian cancer patients.

Aghili L, Foo J, DeGregori J, De S.

Cell Rep. 2014 May 22;7(4):1310-9. doi: 10.1016/j.celrep.2014.03.071. Epub 2014 May 1.

4.

Protein tyrosine phosphatases--from housekeeping enzymes to master regulators of signal transduction.

Tonks NK.

FEBS J. 2013 Jan;280(2):346-78. doi: 10.1111/febs.12077. Epub 2013 Jan 17. Review.

5.

Hypomethylation of dual specificity phosphatase 22 promoter correlates with duration of service in firefighters and is inducible by low-dose benzo[a]pyrene.

Ouyang B, Baxter CS, Lam HM, Yeramaneni S, Levin L, Haynes E, Ho SM.

J Occup Environ Med. 2012 Jul;54(7):774-80. doi: 10.1097/JOM.0b013e31825296bc.

6.

Distinct docking mechanisms mediate interactions between the Msg5 phosphatase and mating or cell integrity mitogen-activated protein kinases (MAPKs) in Saccharomyces cerevisiae.

Palacios L, Dickinson RJ, Sacristán-Reviriego A, Didmon MP, Marín MJ, Martín H, Keyse SM, Molina M.

J Biol Chem. 2011 Dec 9;286(49):42037-50. doi: 10.1074/jbc.M111.286948. Epub 2011 Oct 17.

7.

Myristoylation of the dual-specificity phosphatase c-JUN N-terminal kinase (JNK) stimulatory phosphatase 1 is necessary for its activation of JNK signaling and apoptosis.

Schwertassek U, Buckley DA, Xu CF, Lindsay AJ, McCaffrey MW, Neubert TA, Tonks NK.

FEBS J. 2010 Jun;277(11):2463-73. doi: 10.1111/j.1742-4658.2010.07661.x.

8.

JNK pathway-associated phosphatase dephosphorylates focal adhesion kinase and suppresses cell migration.

Li JP, Fu YN, Chen YR, Tan TH.

J Biol Chem. 2010 Feb 19;285(8):5472-8. doi: 10.1074/jbc.M109.060186. Epub 2009 Dec 14.

9.

Comparison of human B cell activation by TLR7 and TLR9 agonists.

Hanten JA, Vasilakos JP, Riter CL, Neys L, Lipson KE, Alkan SS, Birmachu W.

BMC Immunol. 2008 Jul 24;9:39. doi: 10.1186/1471-2172-9-39.

10.

Spatiotemporal regulation of ERK2 by dual specificity phosphatases.

Caunt CJ, Armstrong SP, Rivers CA, Norman MR, McArdle CA.

J Biol Chem. 2008 Sep 26;283(39):26612-23. doi: 10.1074/jbc.M801500200. Epub 2008 Jul 23.

11.

Characterization of a novel low-molecular-mass dual-specificity phosphatase-3 (LDP-3) that enhances activation of JNK and p38.

Takagaki K, Satoh T, Tanuma N, Masuda K, Takekawa M, Shima H, Kikuchi K.

Biochem J. 2004 Nov 1;383(Pt. 3):447-55.

Supplemental Content

Support Center